Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 4/20 | 0.48 |
| ▸ | FDPS | P14324 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | DNM1 | Q05193 | 8/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL161035 | 1.00 | SMPD1 (0.48) | SMPD1FDPSTSHRTHRBDNM1 | |
| SCHEMBL11597473 | 1.00 | SMPD1 (0.48) | SMPD1FDPSTSHRTHRBDNM1 | |
| SCHEMBL123602 | 1.00 | SMPD1 (0.48) | SMPD1FDPSTSHRTHRBDNM1 | |
| SCHEMBL162599 | 1.00 | SMPD1 (0.48) | SMPD1FDPSTSHRTHRBDNM1 | |
| SCHEMBL161834 | 1.00 | SMPD1 (0.48) | SMPD1FDPSTSHRTHRBDNM1 | |
| SCHEMBL160808 | 1.00 | SMPD1 (0.48) | SMPD1FDPSTSHRTHRBDNM1 | |
| SCHEMBL8981471 | 1.00 | SMPD1 (0.48) | SMPD1FDPSTSHRTHRBDNM1 | |
| SCHEMBL613861 | 1.00 | SMPD1 (0.48) | SMPD1FDPSTSHRTHRBDNM1 | |
| SCHEMBL8383508 | 1.00 | SMPD1 (0.48) | SMPD1FDPSTSHRTHRBDNM1 | |
| SCHEMBL4881471 | 1.00 | SMPD1 (0.48) | SMPD1FDPSTSHRTHRBDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114259466-B | Chitosan microemulsion for percutaneous administration of curcumin and preparation method thereof | 华南理工大学 | 2023-06-16 | — | — | CN | claimed |
| EP-1319040-B1 | POLYMER-ORGANOCLAY COMPOSITE COMPOSITIONS, METHOD FOR MAKING AND ARTICLES THEREFROM | SABIC INNOVATIVE PLASTICS IP (NL) | 2014-08-20 | — | — | EP | claimed |
| EP-1319040-A1 | POLYMER-ORGANOCLAY COMPOSITE COMPOSITIONS, METHOD FOR MAKING AND ARTICLES THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2003-06-18 | — | — | EP | claimed |
| US-6423768-B1 | MIXTURES CONTAINING POLYAMIDES, POLYPHENYLENE ETHER AND IMPACT STRENGTH ADJUVANTS | GENERAL ELECTRIC COMPANY | 2002-07-23 | — | — | US | claimed |
| WO-2002022729-A1 | POLYMER-ORGANOCLAY COMPOSITE COMPOSITIONS, METHOD FOR MAKING AND ARTICLES THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2002-03-21 | — | — | WO | claimed |
| EP-0707489-A4 | ATHEROSCLEROTIC PLAQUE SPECIFIC ANTIGENS, ANTIBODIES THERETO, AND USES THEREOF | SCOTGEN BIOPHARMACEUTICALS INC (US) | 1998-07-29 | — | — | EP | claimed |
| EP-0707489-A1 | ATHEROSCLEROTIC PLAQUE SPECIFIC ANTIGENS, ANTIBODIES THERETO, AND USES THEREOF | Scotgen Biopharmaceuticals, Inc. (US) | 1996-04-24 | — | — | EP | claimed |
| WO-1994025053-A1 | ATHEROSCLEROTIC PLAQUE SPECIFIC ANTIGENS, ANTIBODIES THERETO, AND USES THEREOF | SCOTGEN BIOPHARMACEUTICALS, INC. (US) | 1994-11-10 | — | — | WO | claimed |
| WO-2024141243-A1 | EPOXIDE-BASED COMPOSITION | EVONIK OPERATIONS GMBH (DE) | 2024-07-04 | — | — | WO | disclosed |
| US-20230399550-A1 | BASE-RELEASING COMPOSITION AND CURABLE RESIN COMPOSITION USING THE SAME | NAMICS CORPORATION (JP) | 2023-12-14 | — | — | US | disclosed |
| CN-117120020-A | Implantable medical device for delivery of nucleic acid encapsulated particles | 塞拉尼斯伊娃高性能聚合物公司 | 2023-11-24 | — | — | CN | disclosed |
| EP-4239025-A1 | BASE-RELEASING COMPOSITION AND CURABLE RESIN COMPOSITION USING SAME | Namics Corporation (JP) | 2023-09-06 | — | — | EP | disclosed |
| CN-116323712-A | Alkali releasing composition and curable resin composition using same | 纳美仕有限公司 | 2023-06-23 | — | — | CN | disclosed |
| WO-2022091989-A1 | BASE-RELEASING COMPOSITION AND CURABLE RESIN COMPOSITION USING SAME | ナミックス株式会社 | 2022-05-05 | — | — | WO | disclosed |
| EP-0519406-A2 | Novel perfluoropolyether derivatives, and lubricants and magnetic recording medium using the same | SONY CORPORATION (JP) | 1992-12-23 | — | — | EP | disclosed |
| US-5128396-A | Corrosion inhibiting primers on metallic substrates | CIBA-GEIGY CORPORATION (US) | 1992-07-07 | — | — | US | disclosed |
| US-5120738-A | Cardiovascular disorders | FUJIREBIO INC. (JP) | 1992-06-09 | — | — | US | disclosed |
| EP-0421441-A2 | Pantothenic acid derivatives | FUJIREBIO INC. (JP) | 1991-04-10 | — | — | EP | disclosed |
| EP-0375614-A1 | Corrosion-inhibiting coating compositions | CIBA-GEIGY AG (CH) | 1990-06-27 | — | — | EP | disclosed |
| US-4390712-A | Aqueous solution of cationic organosilicon compounds and process for the production of the solutions | DEGUSSA AG (DE) | 1983-06-28 | — | — | US | disclosed |